
Sign up to save your podcasts
Or
7investing's Watch List of New Ideas introduces stocks that we've never formally recommended yet are worth considering as future scorecard additions. You can think of this as our pipeline of new investment opportunities.
This month, 7investing CEO Simon Erickson is adding two new two European companies: BE Semiconductor (OTC: BESIY) and Novo Nordisk (NYSE: NVO). He describes why Besi's advanced packaging leadership makes it a natural winner from innovative new chip designs, and why Novo Nordisk is still in the earliest innings of introducing Ozempic as a treatment for obesity.
7investing makes its formal recommendations available through its Premium Membership. To see all of our stock market recommendations through a 100% free 7 day trial, join today at 7investing.com/subscribe.
4.1
8787 ratings
7investing's Watch List of New Ideas introduces stocks that we've never formally recommended yet are worth considering as future scorecard additions. You can think of this as our pipeline of new investment opportunities.
This month, 7investing CEO Simon Erickson is adding two new two European companies: BE Semiconductor (OTC: BESIY) and Novo Nordisk (NYSE: NVO). He describes why Besi's advanced packaging leadership makes it a natural winner from innovative new chip designs, and why Novo Nordisk is still in the earliest innings of introducing Ozempic as a treatment for obesity.
7investing makes its formal recommendations available through its Premium Membership. To see all of our stock market recommendations through a 100% free 7 day trial, join today at 7investing.com/subscribe.
3,195 Listeners
3,369 Listeners
939 Listeners
394 Listeners
2,000 Listeners
88 Listeners
188 Listeners
306 Listeners
384 Listeners
2,058 Listeners
563 Listeners
1,546 Listeners
195 Listeners
353 Listeners
469 Listeners